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Disorders of sex development (DSD) and hypogonadism are
genetically heterogeneous and include a broad spectrum of
phenotypes. Recent advances in biology and medicine have
introduced impressive improvements in both clinical man-
agement and structured research, mainly in new technologies
to study their genetic features and the mechanisms underly-
ing their pathologies. Knowledge and understanding of these
conditions have led to the development of successful thera-
pies and novel tools to characterize them and provide better
care to patients. Therefore, both DSD and hypogonadism
represent an important field in research and clinical setting.
This special issue presents a series of articles mainly
reflecting the difficulties in characterization of DSD in four
papers, advances in genetics of DSD in two papers, hypogo-
nadotropic hypogonadism in one paper, clinical presentation
of male primary hypogonadism, like Klinefelter’s syndrome
in one paper, and long-term followup of female hyperg-
onadotropic hypogonadism in one paper, as well as clinical
and molecular data of aromatase excess syndrome in one
paper and an interesting review about the complex associ-
ation of androgens and adipose tissue in males in one paper.
Juniarto and colleagues in their paper “Application of the
new classification on patients with a disorder of sex devel-
opment in Indonesia” from Indonesia showed how patients’
and general society’s opinion on DSD, economic background
of the patients, and lack of access to health insurance can
affect the complex management of DSD in a negative way.
Probably, these situations are not restricted to Indonesia, but
to all underdeveloped countries, and education of primary
health care workers is necessary to prevent morbidity and
mortality in some cases. Hersmus and colleagues in their
paper “Delayed recognition of disorders of sex development
(DSD): a missed opportunity for early diagnosis of malig-
nant germ cell tumors” reported three independent male
patients with germ cell tumors retrospectively recognized as
DSD, showing again, but now in a developed country, the
underdiagnosis of DSD in the newborn and the significant
relevance of early and correct evaluation for identification
of individuals at increased risk for development a gonadal
tumor. Wünsch’s paper “Checklist for the structural descrip-
tion of the deep phenotypes in disorders of sexual devel-
opment” suggest an interesting checklist for the structural
description of gonads and internal sex ducts using video
endoscopy and laparoscopy, which can contribute to a com-
prehensive definition of the variations of deep phenotype in
DSD. Veiga-Junior and colleagues in their paper “Clinical
and laboratorial features that may differentiate 46,XY DSD
due to partial androgen insensitivity and 5α-reductase type 2
deficiency”, evaluating 58 patients with sex ambiguity, 46,XY
karyotype, and normal testosterone secretion, reported
clinical and laboratorial features, like consanguinity, familial
recurrence, severity of ambiguous genitalia, penile length,
and T/DHT ratio, which may differentiate 46,XY DSD due to
partial androgen insensitivity and 5α-reductase deficiency.
2 International Journal of Endocrinology
Barbaro and colleagues in their paper “Multigeneration
inheritance through fertile XX carriers of an NR0B1 (DAX1)
locus duplication in a kindred of females with isolated XY
gonadal dysgenesis” identified another NR0B1 duplication
in two sisters with isolated XY gonadal dysgenesis and an
X-linked inheritance pattern. They also studied three fertile
female carriers of three different small NR0B1 locus dupli-
cations and did not find obvious skewing of X-chromosome
inactivation, suggesting that NR0B1 overexpression does not
impair ovarian function. Mooslehner and colleagues in their
paper “A cell model for conditional profiling of androgen-
receptor-interacting proteins” reported preliminary results
that allow future studies to focus on replacing wild-type
androgen receptor (AR) with mutant AR to uncover dif-
ferences in protein interactions caused by AR mutations
involved in partial androgen insensitivity syndrome.
Beate and colleagues in their paper “Genetics of iso-
lated hypogonadotropic hypogonadism: role of GnRH recep-
tor and other genes” showed an interesting revision about
the genetics of isolated hypogonadotropic hypogonadism
and the importance of inactivating mutations in the pitu-
itary GnRH receptor inducing GnRH resistance in patients
with normosmic isolated hypogonadotropic hypogonadism.
Pacenza and colleagues in their paper “Clinical presentation
of Klinefelter’s syndrome: differences according to age”, eval-
uating 94 patients with Klinefelter’s syndrome, showed that
46.8% were diagnosed between 11 and 20 years, probably
because nowadays pediatricians are more aware that boys
and adolescents with neurodevelopmental disorders and
cryptorchidism should be investigated for this chromosome
anomaly. Pantelis and colleagues in their paper “Long-term
followup of adolescent and young adult females with hyper-
gonadotropic hypogonadism” showed that all prepubertal
girl, teenager, or young woman diagnosed with prima-
ry ovarian insufficiency should undergo extensive research
by a group of specialists in a referral center, and the final
decision of therapy should be taken by the patient and her
clinician.
Fukami and colleagues in their paper “Molecular bases
and phenotypic determinants of aromatase excess syndrome”
showed that aromatase excess syndrome represents a novel
model for gain-of-function mutation leading to human
genetic disorders characterized by gynecomastia. Mammi
and colleagues in their paper “Androgens and adipose tissue
in males: a complex and reciprocal interplay” reported an
interesting revision about the association between andro-
gens and adipose tissue in males. The authors concluded
that adequate levels and balance of circulating sex hormones
are necessary to maintain a correct distribution and size of
adipose tissue, which in turn is fundamental to keep a normal
reproductive and sexual function.
Our understanding in DSD and hypogonadism is ad-
vancing, and we hope that the readers will find this special
issue enjoyable and helpful in the clinical practice. In
addition, we would like to take the opportunity to express
our gratitude and thanks to all the authors involved in this
selected issue for the high-level papers they submitted. We
also thank the reviewers for their time and expertise as well as
the Editor-Chief of International Journal of Endocrinology
for giving us the honor to publish this important special
issue. Enjoy this special issue of DSD and hypogonadism!
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